Quoin Pharmaceuticals EBITDA vs. Current Ratio
| QNRX Stock | USD 0.66 0.07 9.59% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -9.3 M | Current Value -8.8 M | Quarterly Volatility 12.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.1 | 1.3 |
|
|
For Quoin Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Quoin Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Quoin Pharmaceuticals Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Quoin Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Quoin Pharmaceuticals Ltd over time as well as its relative position and ranking within its peers.
Quoin |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quoin Pharmaceuticals. If investors know Quoin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quoin Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.66) | Return On Assets (0.36) | Return On Equity (1.00) |
The market value of Quoin Pharmaceuticals is measured differently than its book value, which is the value of Quoin that is recorded on the company's balance sheet. Investors also form their own opinion of Quoin Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Quoin Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quoin Pharmaceuticals' market value can be influenced by many factors that don't directly affect Quoin Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quoin Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quoin Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quoin Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Quoin Pharmaceuticals Current Ratio vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Quoin Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Quoin Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Quoin Pharmaceuticals Ltd is rated below average in ebitda category among its peers. It is rated below average in current ratio category among its peers . Quoin Pharmaceuticals reported EBITDA of (9.27 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quoin Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Quoin Current Ratio vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Quoin Pharmaceuticals |
| = | (9.27 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Quoin Pharmaceuticals |
| = | 0.96 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Quoin Current Ratio Comparison
Quoin Pharmaceuticals is currently under evaluation in current ratio category among its peers.
Quoin Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Quoin Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Quoin Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Quoin Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Quoin Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -9.4 M | -8.9 M | |
| Income Before Tax | -8.7 M | -8.2 M | |
| Net Loss | -8.7 M | -9.1 M | |
| Net Interest Income | 616.7 K | 647.5 K | |
| Net Loss | -8.6 M | -9.1 M | |
| Total Other Income Expense Net | 714.3 K | 750 K | |
| Net Loss | -8.5 M | -8.9 M | |
| Income Tax Expense | 22.4 K | 23.5 K | |
| Interest Income | 616.7 K | 647.5 K | |
| Change To Netincome | 1 M | 973.5 K | |
| Net Loss | (9.64) | (9.16) | |
| Income Quality | 0.91 | 0.86 | |
| Net Income Per E B T | 1.00 | 0.65 |
Quoin Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Quoin Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Quoin Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Quoin Pharmaceuticals' important profitability drivers and their relationship over time.
Use Quoin Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quoin Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Quoin Pharmaceuticals Pair Trading
Quoin Pharmaceuticals Ltd Pair Trading Analysis
The ability to find closely correlated positions to Quoin Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quoin Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quoin Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quoin Pharmaceuticals Ltd to buy it.
The correlation of Quoin Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quoin Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quoin Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quoin Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Quoin Pharmaceuticals position
In addition to having Quoin Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Companies from entertainment industry including show business, news and media. The Entertainment theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.